Skip to main content
. 2003 Nov;163(5):1713–1719. doi: 10.1016/s0002-9440(10)63529-8

Figure 2.

Figure 2.

Tumor spectrum is changed in tTA/TAg/ER-α transgenic mice. Mammary adenocarcinomas developed only in triple-transgenic tTA/TAg/ER-α mice (females, n = 10; males, n = 1). Significantly fewer triple-transgenic females develop lymphomas than double-transgenic females (*, P = 0.014; chi-square test). M & S, development of both mammary and salivary adenocarcinomas.